Lates News

According to the AI Fast News of Every Economy, Hua Yuan Securities released a research report on September 12th, giving Mindray Medical (300760.SZ) a buy rating. The reasons for the rating mainly include: 1) it is a leading company in the medical device industry, accelerating its entry into the global leading group; 2) the domestic procurement is expected to pick up and the international localization network is gradually forming; 3) double-wheel drive strengthens the product matrix, and the business is transitioning towards consumables; 4) the domestic and international market share is expected to continue to increase, and the global device platform valuation may be reconstructed. (Daily Economic News)